The Supreme Court declined to intervene in a case challenging access to mifepristone, the drug used in medication abortion. The justices allowed the lower court's ruling to stand, preserving mail-based access to the abortion pill for the present time.

The decision came in response to an emergency appeal from abortion providers seeking to block enforcement of restrictions imposed by the Fifth Circuit Court of Appeals. That court had previously ruled that mifepristone access could be limited, though it stayed its own order pending further legal proceedings. The Supreme Court's refusal to grant the emergency stay means the Fifth Circuit's more permissive standard remains in effect.

The case centers on how far federal regulators can restrict mifepristone under the Risk Evaluation and Mitigation Strategy program, known as REMS. Anti-abortion groups challenged the FDA's 2023 decision to expand access to the drug by permitting mail distribution and relaxing age verification requirements. They argued the agency exceeded its authority under the Comstock Act, a 19th-century statute prohibiting mailing of abortifacients.

The Fifth Circuit sided partly with the challengers, imposing several conditions on mifepristone distribution. However, the court stayed its injunction, allowing current practices to continue while appeals proceed. The Supreme Court's action preserving that status quo protects the existing distribution network for now but signals no final resolution on the underlying constitutional and statutory questions.

The ruling carries immediate implications for abortion providers and patients in states without abortion bans. Patients can continue ordering mifepristone through telemedicine and receiving it by mail in compliance with current FDA guidelines. However, the decision provides no lasting protection. The case remains active in lower courts, and the Supreme Court may eventually address the merits of whether federal law restricts mifepristone access.

Anti-abortion advocates view the Fifth Circuit decision as a potential